Boston Scientific Recalls All Implantable Defibrillators, Suspends Sales

Boston Scientific is recalling all lines of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators nationwide because the firm made manufacturing process changes without proper FDA approval

More from Archive

More from Medtech Insight